Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27549647

CC(C)(C)OC=O.Clc1ccccn1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.57
▸ NFE2L2 Q16236 7/20 0.35
▸ MAPK1 P28482 2/20 0.34
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ GRM5 P41594 1/20 0.32
▸ SMARCA2 P51531 1/20 0.32
▸ SMARCA4 P51532 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ XBP1 P17861 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Chloropyridine SCHEMBL27296934 0.83 TDP1 (0.64) TDP1NFE2L2NPC1RAB9AMEN1
Dipyridyl SCHEMBL27745333 0.81 KDM4E (0.54) TDP1MAPK1NPC1RAB9AATM
2-Chloropyridine SCHEMBL9366854 0.80 — —
Tert-Butyl Formate SCHEMBL27787932 0.79 TDP1 (0.52) TDP1NFE2L2MEN1KMT2AALDH1A1
2-Chloropyridine SCHEMBL28283236 0.79 TDP1 (0.64) TDP1NFE2L2NPC1RAB9AMEN1
Tert-Butyl Formate SCHEMBL27580501 0.79 TDP1 (0.46) TDP1NFE2L2MAPK1NPC1RAB9A
2-Chloropyridine SCHEMBL27506304 0.78 TDP1 (0.76) TDP1NFE2L2NPC1RAB9AMEN1
Tert-Butyl Formate SCHEMBL28100934 0.77 TDP1 (0.54) TDP1NFE2L2NPC1RAB9ASMN1; SMN2
2-Chloropyridine SCHEMBL27596465 0.77 TDP1 (0.73) TDP1NFE2L2NPC1RAB9AMEN1
2-Chloropyridine SCHEMBL28292211 0.77 TDP1 (0.73) TDP1NFE2L2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110267948-A Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and methods of making the modulators 弗特克斯药品有限公司 2019-09-20 — — CN disclosed
CN-109476658-A Substituted 5,6,7,8- tetrahydro [1,2,4] triazol [4,3-A] pyridine -3 (2H) -one and 2,5,6,7- tetrahydro -3H- pyrrolo- [2,1-c] [1,2,4] triazole -3- ketone and application thereof 拜耳公司 2019-03-15 — — CN disclosed
CN-102333776-A Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof SANOFI AVENTIS 2012-01-25 — — CN disclosed
CN-100352804-C Amide derivatives ASTRAZENECA AB (SE) 2007-12-05 — — CN disclosed
CN-1344249-A Amide derivatives ASTRAZENECA AB (SE) 2002-04-10 — — CN disclosed
Send feedback